New test can predict cancer up to 13 years before it hits

Test works with 100 per cent accuracy

Henry Austin
Friday 01 May 2015 07:03 BST
Comments
Data indicates that the UK is still behind its European counterparts in treating cancer
Data indicates that the UK is still behind its European counterparts in treating cancer (Getty Images)

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

Scientists have developed a new test that can predict with 100 per cent accuracy whether someone will develop cancer up to 13 years in the future.

The discovery of tiny but significant changes taking place in the body more than a decade before cancer was diagnosed helped researchers at Harvard and Northwestern University make the breakthrough.

Their research, published in the online journal Ebiomedicine, found protective caps on the ends of chromosomes, which prevent DNA damage were more worn down those who went on to develop cancer.

Known as telomeres, these were much shorter than they should have been and continued to get shorter until around four years before the cancer developed, when they suddenly stopped shrinking.

“Because we saw a strong relationship in the pattern across a wide variety of cancers, with the right testing these procedures could be used eventually to diagnose a wide variety of cancers,” said Dr Lifang Hou, the lead study author, told The Telegraph.

“Understanding this pattern of telomere growth may mean it can be a predictive biomarker for cancer….We found cancer has hijacked the telomere shortening in order to flourish in the body.”

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in